Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exelixis Inc (NASDAQ:EXEL)

11.61
Delayed Data
As of Aug 23
 +0.17 / +1.49%
Today’s Change
3.55
Today|||52-Week Range
11.70
+105.85%
Year-to-Date
4 Biotech Stock Charts You Must See
Aug 23 / TheStreet.com - Paid Partner Content
2 Factors Pushing Exelixis, Inc. Up by 18% in July
Aug 08 / MotleyFool.com - Paid Partner Content
This Could Be August's Best Stock
Aug 09 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close11.44
Today’s open11.46
Day’s range11.42 - 11.70
Volume5,241,620
Average volume (3 months)5,960,288
Market cap$2.6B
Dividend yield--
Data as of 3:59pm ET, 08/23/2016

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)+14.81%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+48.03%
P/E ratioNM
Price/Sales31.75
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INCRINC Research Holding...+0.86+1.87%
PRAHPRA Health Sciences ...+0.84+1.62%
DBVTDBV Technologies SA+0.40+1.16%
PRXLPAREXEL Internationa...0.000.00%
Data as of 4:00pm ET, 08/23/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$37.2M
Annual profit (last year)-$169.7M
Net profit margin-456.63%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs